Ra’anana, Israel December 29th, 2020;
QART Medical Ltd. has won the 3rd (monetary) prize in the 2020 Qingdao High-tech Zone Lanebest International Innovation and Entrepreneurship Competition
(see: https://mp.weixin.qq.com/s/G5yFvTKazCeOrB1k607tCw). Due to COVID-19 travel limitations, QART business case was pitched by Ms. Rowling Wang, Project Manager at Quantum China Israel Innovations (QCII) (see images below). Congratulations for the good work!
About QART Medical QART Medical
(see: https://www.qart-medical.com/) is developing a novel system called QISITM (Quantitative Interferometric Sperm Imager) – allowing the embryologist to make highly informed decisions, when selecting individual sperm cells for injection into the (female) egg in a dish, in a procedure called ICSI (intra-cytoplasmic sperm injection).
Today, individual sperm cells are mostly selected according to their gross head shape, external “silhouette” and their swimming trajectory. The QISITM system in designed to allow embryologists to benchmark all consensus criteria, included in the World Health Organization 2010’s guidebook to IVF clinics, in addition to key indications, pertaining to the level of DNA fragmentation.
QART intends to conduct initial lab studies with its system in H1 ’21. The company was established around the technology of Prof. Natan T. Shaked together with Ramot, the technology transfer arm of Tel Aviv University (see: https://ramot.org/), the Momentum Fund (see: https://ramot.org/industry-investors/momentum-fund) and is run by Alon Shalev, its co-founder.
About QCII Quantum China Israel Innovations
(QCII, https://www.quantumcii.com/) brings together Israeli and Chinese companies in a novel entrepreneurial model, leveraging their complementary strengths in joint ventures designed to solve highly defined economic problems. QCII is based in Tel-Aviv, Israel and in Qingdao and Jinan- Shandong province in China with bi-nationaland experienced team, comprised of seasoned entrepreneurs, successful business people, distinguished policy advisors and academics. QCII has local presence and vast network both in china and Israel.